Old Web
English
Sign In
Acemap
>
authorDetail
>
Meheryar Rivetna
Meheryar Rivetna
Merck & Co.
Biochemistry
Peptide
Chemistry
Stereochemistry
Organic chemistry
4
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate.
1999
Bioorganic & Medicinal Chemistry Letters
A. Brian Jones
John J. Acton
Meheryar Rivetna
Richard T. Cummings
Rose M. Cubbon
Elizabeth A. Nichols
Cheryl D. Schwartz
Linda S. Wicker
Jeffrey D. Hermes
Show All
Source
Cite
Save
Citations (3)
SAR for MHC class II binding tetrapeptides: Correlation with potential binding site
1997
Bioorganic & Medicinal Chemistry Letters
Barry R. Cunningham
Meheryar Rivetna
Richard L. Tolman
Stacey J Flattery
Elizabeth A. Nichols
Cheryl D. Schwartz
Linda S. Wicker
Jeffrey D. Hermes
A. Brian Jones
Show All
Source
Cite
Save
Citations (6)
A MEDICINAL CHEMISTRY EVALUATION OF THE AUTOINHIBITORY DOMAIN OF CALCINEURIN
1995
Bioorganic & Medicinal Chemistry Letters
Meheryar Rivetna
Scott P. Salowe
Richard L. Tolman
A. Brian Jones
Show All
Source
Cite
Save
Citations (4)
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens.
1994
Vaccine
Anthony J. Conley
Patricia Conard
Steven S. Bondy
Catherine A. Dolan
John Hannah
William J. Leanza
Stephen Marburg
Meheryar Rivetna
Victoria K. Rusiecki
Elizabeth E. Sugg
Francis Van Middlesworth
Susan A. Warne
J. Terry Ulrich
Jon A. Rudbach
Richard L. Tolman
Emilio A. Emini
Show All
Source
Cite
Save
Citations (31)
1